Abstract
ASO Author Reflections: Is There an Extra Benefit of Adding Neoadjuvant Radiotherapy to Chemotherapy in Patients with (Borderline) Resectable Pancreatic Cancer?
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have